Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p

The usage of doxorubicin is hampered by its life-threatening cardiotoxicity in clinical practice. Dexrazoxane is the only cardioprotective medicine approved by the FDA for preventing doxorubicin-induced cardiac toxicity. Nevertheless, the mechanism of dexrazoxane is incompletely understood. The aim...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biomed Res Int
Huvudupphovsmän: Yu, Xiaoxue, Ruan, Yang, Shen, Tao, Qiu, Quan, Yan, Mingjing, Sun, Shenghui, Dou, Lin, Huang, Xiuqing, Wang, Que, Zhang, Xiyue, Man, Yong, Tang, Weiqing, Jin, Zening, Li, Jian
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi 2020
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7071803/
https://ncbi.nlm.nih.gov/pubmed/32190669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5107193
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk